36
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Requirement for the NF-κB Family Member RelA in the Development of Secondary Lymphoid Organs

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The transcription factor nuclear factor (NF)-κB has been suggested to be a key mediator of the development of lymph nodes and Peyer's patches. However, targeted deletion of NF-κB/ Rel family members has not yet corroborated such a function. Here we report that when mice lacking the RelA subunit of NF-κB are brought to term by breeding onto a tumor necrosis factor receptor (TNFR)1-deficient background, the mice that are born lack lymph nodes, Peyer's patches, and an organized splenic microarchitecture, and have a profound defect in T cell–dependent antigen responses. Analyses of TNFR1/RelA-deficient embryonic tissues and of radiation chimeras suggest that the dependence on RelA is manifest not in hematopoietic cells but rather in radioresistant stromal cells needed for the development of secondary lymphoid organs.

          Related collections

          Most cited references62

          • Record: found
          • Abstract: found
          • Article: not found

          An essential role for NF-kappaB in preventing TNF-alpha-induced cell death.

          Studies on mice deficient in nuclear factor kappa B (NF-kappaB) subunits have shown that this transcription factor is important for lymphocyte responses to antigens and cytokine-inducible gene expression. In particular, the RelA (p65) subunit is required for induction of tumor necrosis factor-alpha (TNF-alpha)-dependent genes. Treatment of RelA-deficient (RelA-/-) mouse fibroblasts and macrophages with TNF-alpha resulted in a significant reduction in viability, whereas RelA+/+ cells were unaffected. Cytotoxicity to both cell types was mediated by TNF receptor 1. Reintroduction of RelA into RelA-/- fibroblasts resulted in enhanced survival, demonstrating that the presence of RelA is required for protection from TNF-alpha. These results have implications for the treatment of inflammatory and proliferative diseases.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B.

              NF-kappa B, which consists of two polypeptides, p50 (M(r) 50K) and p65/RelA (M(r) 65K), is thought to be a key regulator of genes involved in responses to infection, inflammation and stress. Indeed, although developmentally normal, mice deficient in p50 display functional defects in immune responses. Here we describe the generation of mice deficient in the RelA subunit of NF-kappa B. Disruption of the relA locus leads to embryonic lethality at 15-16 days of gestation, concomitant with a massive degeneration of the liver by programmed cell death or apoptosis. Embryonic fibroblasts from RelA-deficient mice are defective in the tumour necrosis factor (TNF)-mediated induction of messenger RNAs for I kappa B alpha and granulocyte/macrophage colony stimulating factor (GM-CSF), although basal levels of these transcripts are unaltered. These results indicate that RelA controls inducible, but not basal, transcription in NF-kappa B-regulated pathways.
                Bookmark

                Author and article information

                Journal
                J Exp Med
                The Journal of Experimental Medicine
                The Rockefeller University Press
                0022-1007
                1540-9538
                21 January 2002
                : 195
                : 2
                : 233-244
                Affiliations
                [1 ]Center for Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139
                [2 ]Whitehead Institute, Cambridge, MA 02142
                [3 ]Biogen Inc., Cambridge, MA 02142
                [4 ]California Institute of Technology, Pasadena, CA 91125
                Author notes

                Address correspondence to Dr. Nir Hacohen, Whitehead Institute, 9 Cambridge Center, Cambridge, MA 02142. Phone: 617-258-9205; Fax: 617-258-5578; E-mail: hacohen@ 123456wi.mit.edu

                Article
                011885
                10.1084/jem.20011885
                2193608
                11805150
                a7c7a212-ee79-417a-87d0-f2f7fa9218fd
                Copyright © 2002, The Rockefeller University Press
                History
                : 13 November 2001
                : 30 November 2001
                Categories
                Original Article

                Medicine
                spleen,p65,tnfr1,lymph nodes,peyer's patches
                Medicine
                spleen, p65, tnfr1, lymph nodes, peyer's patches

                Comments

                Comment on this article